Natural and synthetic PPARγ ligands demonstrated to counteract the activity of different MMPs in different breast cancer cell lines, suggesting their potential role in enhancing the effectiveness of the standard breast cancer chemotherapeutic agents in a multidrug therapeutic approach [6,102,103]. Here, PPARG is linked to breast carcinoma.